Overview
Bronchiectasis is a heterogenous disease with multiple aetiology. There are around 100 potential cause for the pathophysiology of bronchiectasis. Finding of right treatment to right patient depending upon clinical practice is the basis of treatable traits.
Faculty
Prof James Chalmers
MBChB, PhD
Professor and Consultant Respiratory Physician, University of Dundee, UK Chair of the European Bronchiectasis Registry (EMBARC); Chair of the 2017 European Bronchiectasis Guidelines; Deputy Chief editor of the ER; Member of the International Advisory Board of the Lancet Respiratory Medicine; Secretary of the European Board for Accreditation in Pneumology.Resources
External Resources
Treatable Traits in Bronchiectasis
Also Read
